Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, especially for cancers where treatment possibilities remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/what-copyright-to-buy-now-to-ride-the-next-100x-bull-run-experts-weigh-in/